• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物粒子溶解的层级传质分析,强调在溶出仪中可电离和不可电离药物溶解的流体力学、pH 值、粒子大小和缓冲液的影响。

Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel.

机构信息

Department of Chemical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States.

Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan,48109, United States.

出版信息

Mol Pharm. 2020 Oct 5;17(10):3870-3884. doi: 10.1021/acs.molpharmaceut.0c00614. Epub 2020 Sep 21.

DOI:10.1021/acs.molpharmaceut.0c00614
PMID:32886520
Abstract

Dissolution is a crucial process for the oral delivery of drug products. Before being absorbed through epithelial cell membranes to reach the systemic circulation, drugs must first dissolve in the human gastrointestinal (GI) tract. and dissolutions are complex because of their dependency upon the drug physicochemical properties, drug product, and GI physiological properties. However, an understanding of this process is critical for the development of robust drug products. To enhance our understanding of and dissolutions, a hierarchical mass transfer (HMT) model was developed that considers the drug properties, GI fluid properties, and fluid hydrodynamics. The key drug properties include intrinsic solubility, acid/base character, p, particle size, and particle polydispersity. The GI fluid properties include bulk pH, buffer species concentration, fluid shear rate, and fluid convection. To corroborate the model, dissolution experiments were conducted in the United States Pharmacopeia (USP) 2 dissolution apparatus. A weakly acidic (ibuprofen), a weakly basic (haloperidol), and a nonionizable (felodipine) drug were used to study the effects of the acid/base character, p, and intrinsic solubility on dissolution. 900 mL of 5 mM bicarbonate and phosphate buffers at pH 6.5 and 37 °C was used to study the impact of the buffer species on drug dissolution. To investigate the impacts of fluid shear rate and convection, the apparatus was operated at different impeller rotational speeds. Moreover, presieved ibuprofen particles with different average diameters were used to investigate the effect of particle size on drug dissolution. experiments demonstrate that the dissolution rates of both the ionizable compounds used in this study were slower in bicarbonate buffer than in phosphate buffer, with the same buffer concentration, because of the lower interfacial buffer capacity, a unique behavior of bicarbonate buffer. Therefore, using surrogates (i.e., 50 mM phosphate) for bicarbonate buffer for biorelevant dissolution testing may overestimate the dissolution rate for ionizable drugs. Model simulations demonstrated that, assuming a monodisperse particle size when modeling, dissolution may overestimate the dissolution rate for polydisperse particle size distributions. The hydrodynamic parameters (maximum shear rate and fluid velocity) under conditions in the USP 2 apparatus under different rotational speeds are orders of magnitude higher compared to the situation. The inconsistencies between the and drug dissolution hydrodynamic conditions may cause an overestimation of the dissolution rate under conditions. The dissolution data supported the accuracy of the HMT for drug dissolution. This is the first drug dissolution model that incorporates the effect of the bulk pH and buffer concentration on the interfacial drug particle solubility of ionizable compounds, combined with the medium hydrodynamics effect (diffusion, convection, shear, and confinement components), and drug particle size distribution.

摘要

溶解是药物口服递送的关键过程。在通过上皮细胞膜吸收到达全身循环之前,药物必须首先在人体胃肠道 (GI) 中溶解。 和 溶解是复杂的,因为它们依赖于药物的物理化学性质、药物产品和 GI 生理特性。然而,对这一过程的理解对于开发稳健的药物产品至关重要。为了增强我们对 和 溶解的理解,开发了一种分层传质 (HMT) 模型,该模型考虑了药物特性、GI 流体特性和流体动力学。关键的药物特性包括内在溶解度、酸碱特性、p、粒径和颗粒多分散性。GI 流体特性包括总体 pH、缓冲物种浓度、流体剪切速率和流体对流。为了验证该模型,在美国药典 (USP) 2 溶解仪中进行了 溶解实验。使用弱酸性 (布洛芬)、弱碱性 (氟哌啶醇) 和非电离 (非洛地平) 药物来研究酸碱特性、p 和内在溶解度对溶解的影响。使用 900 毫升 5 mM 碳酸氢盐和磷酸盐缓冲液在 pH 6.5 和 37°C 下研究缓冲物种对药物溶解的影响。为了研究流体剪切速率和对流的影响,以不同的搅拌器转速操作该仪器。此外,使用不同平均粒径的预筛分布洛芬颗粒研究粒径对药物溶解的影响。 实验表明,本研究中使用的两种可电离化合物在碳酸氢盐缓冲液中的溶解速率比在磷酸盐缓冲液中慢,尽管缓冲液浓度相同,但由于界面缓冲能力较低,碳酸氢盐缓冲液具有独特的行为,因此,使用替代物(即 50mM 磷酸盐)进行碳酸氢盐缓冲液的生物相关 溶解测试可能会高估可电离药物的 溶解速率。模型模拟表明,在对多分散颗粒尺寸分布进行建模时,假设单分散颗粒尺寸可能会高估溶解速率。在不同转速下,USP 2 仪器中的 条件下的流体动力学参数(最大剪切速率和流体速度)与 情况相比 orders of magnitude 高。 和 药物溶解流体动力学条件之间的不一致可能会导致在 条件下高估溶解速率。 溶解数据支持 HMT 用于药物溶解的准确性。这是第一个将可电离化合物的总体 pH 和缓冲浓度对界面药物颗粒溶解度的影响与介质流体动力学效应(扩散、对流、剪切和约束成分)以及药物颗粒尺寸分布相结合的药物溶解模型。

相似文献

1
Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel.药物粒子溶解的层级传质分析,强调在溶出仪中可电离和不可电离药物溶解的流体力学、pH 值、粒子大小和缓冲液的影响。
Mol Pharm. 2020 Oct 5;17(10):3870-3884. doi: 10.1021/acs.molpharmaceut.0c00614. Epub 2020 Sep 21.
2
Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis.利用 pH 调节剂改善具有 pH 依赖性溶解度的药物的溶出行为和口服吸收:一种生理现实的质量传递分析。
Mol Pharm. 2021 Sep 6;18(9):3326-3341. doi: 10.1021/acs.molpharmaceut.1c00262. Epub 2021 Aug 24.
3
Solubility vs Dissolution in Physiological Bicarbonate Buffer.在生理碳酸氢盐缓冲液中的溶解度与溶解
Pharm Res. 2024 May;41(5):937-945. doi: 10.1007/s11095-024-03702-5. Epub 2024 May 2.
4
Dissolution Kinetics of Nifedipine-Ionizable Polymer Amorphous Solid Dispersion: Comparison Between Bicarbonate and Phosphate Buffers.硝苯地平-可离子化聚合物无定形固体分散体的溶出动力学:碳酸氢盐和磷酸盐缓冲液的比较。
Pharm Res. 2021 Dec;38(12):2119-2127. doi: 10.1007/s11095-021-03153-2. Epub 2021 Dec 20.
5
Regulating the pH of bicarbonate solutions without purging gases: Application to dissolution testing of enteric coated tablets, pellets and microparticles.在不吹扫气体的情况下调节碳酸氢盐溶液的 pH 值:在肠溶包衣片剂、丸剂和微丸的溶出度测试中的应用。
Int J Pharm. 2020 Jul 30;585:119562. doi: 10.1016/j.ijpharm.2020.119562. Epub 2020 Jun 18.
6
Comparative Evaluation of Dissolution Performance in a USP 2 Setup and Alternative Stirrers and Vessel Designs: A Systematic Computational Investigation.比较评估在 USP 2 装置和替代搅拌器和容器设计中的溶出性能:系统计算研究。
Mol Pharm. 2024 May 6;21(5):2406-2414. doi: 10.1021/acs.molpharmaceut.3c01203. Epub 2024 Apr 19.
7
Dissolution Profiles of Immediate Release Products of Various Drugs in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer.各种药物速释制剂在生物相关碳酸氢盐缓冲液中的溶出曲线:与药典磷酸盐缓冲液的比较。
Pharm Res. 2024 May;41(5):959-966. doi: 10.1007/s11095-024-03701-6. Epub 2024 Apr 23.
8
In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.在生理碳酸氢盐缓冲液中用于儿科和老年患者的质子泵抑制剂产品的体外溶出度。
Int J Pharm. 2015 May 15;485(1-2):152-9. doi: 10.1016/j.ijpharm.2015.03.008. Epub 2015 Mar 5.
9
Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs.使用生理碳酸氢盐缓冲系统进行可电离药物的溶出特性研究。
Pharm Res. 2003 Oct;20(10):1641-6. doi: 10.1023/a:1026147620304.
10
Ultrathin, Large-Area Membrane Diffusion Cell for pH-Dependent Simultaneous Dissolution and Absorption Studies.用于 pH 依赖性同时溶解和吸收研究的超薄、大面积膜扩散池。
Mol Pharm. 2020 Jul 6;17(7):2319-2328. doi: 10.1021/acs.molpharmaceut.0c00040. Epub 2020 Jun 16.

引用本文的文献

1
Kinetic and Methodological Insights into Hydrophilic Drug Release from Mesoporous Silica Nanocarriers.介孔二氧化硅纳米载体中亲水性药物释放的动力学及方法学见解
Pharmaceutics. 2025 May 25;17(6):694. doi: 10.3390/pharmaceutics17060694.
2
Optimising Cannabidiol Delivery: Improving Water Solubility and Permeability Through Phospholipid Complexation.优化大麻二酚递送:通过磷脂络合提高水溶性和渗透性。
Int J Mol Sci. 2025 Mar 14;26(6):2647. doi: 10.3390/ijms26062647.
3
Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report.
生理药代动力学模型参数化:研讨会总结报告。
Mol Pharm. 2024 Aug 5;21(8):3697-3731. doi: 10.1021/acs.molpharmaceut.4c00526. Epub 2024 Jun 30.
4
Solubility vs Dissolution in Physiological Bicarbonate Buffer.在生理碳酸氢盐缓冲液中的溶解度与溶解
Pharm Res. 2024 May;41(5):937-945. doi: 10.1007/s11095-024-03702-5. Epub 2024 May 2.
5
Dissolution Profiles of Immediate Release Products of Various Drugs in Biorelevant Bicarbonate Buffer: Comparison with Compendial Phosphate Buffer.各种药物速释制剂在生物相关碳酸氢盐缓冲液中的溶出曲线:与药典磷酸盐缓冲液的比较。
Pharm Res. 2024 May;41(5):959-966. doi: 10.1007/s11095-024-03701-6. Epub 2024 Apr 23.
6
Teaching Acid-Base Fundamentals and Introducing pH using Butterfly Pea Flower Tea.利用蝶豆花茶教授酸碱基础知识并介绍pH值
J Chem Educ. 2024 Mar 12;101(3):1373-1378. doi: 10.1021/acs.jchemed.3c01058. Epub 2024 Feb 9.
7
The Use of Physiologically Based Pharmacokinetic Analyses-in Biopharmaceutics Applications -Regulatory and Industry Perspectives.基于生理学的药代动力学分析在生物药剂学应用中的应用——监管和行业视角。
Pharm Res. 2022 Aug;39(8):1681-1700. doi: 10.1007/s11095-022-03280-4. Epub 2022 May 18.
8
Luminal Fluid Motion Inside an In Vitro Dissolution Model of the Human Ascending Colon Assessed Using Magnetic Resonance Imaging.使用磁共振成像评估人体升结肠体外溶解模型内的管腔流体运动。
Pharmaceutics. 2021 Sep 23;13(10):1545. doi: 10.3390/pharmaceutics13101545.
9
Modelling and Simulation of the Drug Release from a Solid Dosage Form in the Human Ascending Colon: The Influence of Different Motility Patterns and Fluid Viscosities.固体剂型药物在人体升结肠中释放的建模与模拟:不同运动模式和流体粘度的影响
Pharmaceutics. 2021 Jun 10;13(6):859. doi: 10.3390/pharmaceutics13060859.
10
Toward Mechanistic Design of Surrogate Buffers for Dissolution Testing of pH-Dependent Drug Delivery Systems.面向pH依赖性药物递送系统溶出度测试替代缓冲液的机制设计
Pharmaceutics. 2020 Dec 10;12(12):1197. doi: 10.3390/pharmaceutics12121197.